Hudson Biotech

This study tests a new weekly injection called retatrutide (LY3437943) to help people with obesity or overweight who also have weight-related health problems like high blood pressure or heart disease. About 300 adults will receive either the drug or a placebo, along with diet and…

This study tests an investigational drug called MOTS-c in 120 adults with prediabetes and overweight or obesity. Participants receive either MOTS-c or a placebo for 12 weeks, along with lifestyle advice. The main goal is to see if MOTS-c improves how the body uses insulin, which …

This study tests whether a daily injection of tesamorelin can safely reduce liver fat in adults with metabolic-associated fatty liver disease (MASLD). About 120 participants will receive either the drug or a placebo for 52 weeks, along with lifestyle advice. The main goal is to m…

This study tests whether adding an investigational drug called Melanotan II to standard light therapy helps restore skin color in adults with stable vitiligo. About 60 participants will receive either the drug or a placebo along with light treatments. The goal is to see if the co…

This study tests a once-weekly injection called tirzepatide in adults who have obesity or are overweight with related health problems, but do not have type 2 diabetes. Participants receive either the drug or a placebo, along with diet and exercise advice. The main goal is to see …

This study tests a new drug called TB-500 in 80 adults with stable heart disease to see if it is safe and tolerable. Participants will receive either TB-500 or a placebo, and researchers will monitor side effects and measure markers of blood vessel health and inflammation. The go…

This study tests whether a gel made with a copper-peptide complex (GHK-Cu) can safely help small skin wounds heal faster than a plain gel. Sixty healthy adults will each get two tiny wounds on their arm, one treated with the copper gel and one with a placebo. Researchers will tra…

This study tests an investigational peptide called BPC 157 to see if it can help heal a moderate hamstring muscle tear faster than standard rehab alone. About 120 adults aged 18 to 45 with a recent, MRI-confirmed grade II hamstring strain will receive either BPC 157 or a placebo …